(Q40831603)

24 September 2017

1 reference

title

Amphotericin B and its delivery by liposomal and lipid formulations (English)

1 reference

24 September 2017

1 reference

Gates C

1

1 reference

24 September 2017

Pinney RJ

series ordinal

2

1 reference

24 September 2017

publication date

1 June 1993

1 reference

Journal of Clinical Pharmacy and Therapeutics

24 September 2017

published in

1 reference

24 September 2017

volume

18

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

147-153

1 reference

Current role of therapy with amphotericin B

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

How do the polyene macrolide antibiotics affect the cellular membrane properties?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Amphotericin B: an introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Sensitivity of Candida albicans to amphotericin B administered as single or fractionated doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Antifungal Agents Useful in Therapy of Systemic Fungal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

In-vitro effects of liposome-encapsulated amphotericin B (AmBisome) and amphotericin B-deoxycholate (Fungizone) on the phagocytic and candidacidal function of human polymorphonuclear leucocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Overview of the treatment of disseminated fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Amphotericin B Pharmacokinetics in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Clinical pharmacokinetics of systemic antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

In vitro tumor necrosis factor induction assay for analysis of febrile toxicity associated with amphotericin B preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Induction of prostaglandin synthesis as the mechanism responsible for the chills and fever produced by infusing amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Randomized, double-blind trial of 1- versus 4-hour amphotericin B infusion durations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

AMPHOTERICIN B TOXICITY; GENERAL SIDE EFFECTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Liposomes as drug delivery system in the treatment of infectious diseases. Potential applications and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Liposomes as carriers of antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

21 January 2018

Overview of liposomes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Amphotericin B lipid complex therapy of experimental fungal infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Comparative Safety, Tolerance, and Pharmacokinetics of Amphotericin B Lipid Complex and Amphotericin B Desoxycholate in Healthy Male Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Single-dose pharmacokinetics and tolerance of a cholesteryl sulfate complex of amphotericin B administered to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Future directions of antifungal chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

Cardiopulmonary toxicity after liposomal amphotericin B infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1993.TB00605.X

10.1111/J.1365-2710.1993.TB00605.X

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference